Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc. (ERNA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ERNA · as of Jun 8, 2026
Key Statistics
Explore Ernexa Therapeutics Inc. Data
erna stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
erna competitorsERNA
ADAP
AEMD
AEON
DWTX
LNAIStock Performance
Full HistoryAbout Ernexa Therapeutics Inc.
Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs).…
what is ernexa therapeutics inc. · erna stock overview · ernexa therapeutics inc. company profile · who is ernexa therapeutics inc. ceo · erna NASDAQ · ernexa therapeutics inc. headquarters · ernexa therapeutics inc. business segments
About Stock Overview & Key Data
Ernexa Therapeutics Inc. (ERNA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 29, 1991. As of the latest trading session, ERNA stock price is $7.41, with a market capitalization of $2.4M. The stock has returned -89.38% over the past 12 months and -74.87% year-to-date.
In fiscal year 2025, Ernexa Therapeutics Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ernexa Therapeutics Inc. (ERNA) stock price is $7.41. The stock is traded on NASDAQ under the ticker symbol ERNA. The 52-week range is $3.18 – $75.00.